🔎 Trials Near Me

Akèy › Sistèm Imunitè ak Twoub › Kalifòni › Los Angeles

Etid klinik pou Sistèm Imunitè ak Twoub nan Los Angeles, CA

8 etid pou Sistèm Imunitè ak Twoub ap chèche patisipan nan sit nan ak bò kote Los Angeles (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Ap rekriteFaz 3
  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06722235

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Ap rekriteFaz 2
  • UCLA Medical Center, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04996875

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Ap rekriteFaz 3
  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06948318

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Ap rekriteFaz 1/2
  • Cedars-Sinai Medical Center, Los Angeles
  • University of California, Los Angeles (UCLA) Medical Center, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05826535

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Ap rekriteFaz 2
  • Inmagene Site 23, Los Angeles
Laj 18 a 74 · Tout sèks · Mizajou Aug 12, 2026 · NCT07037901

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Ap rekriteFaz 2
  • UCLA Department of Medicine, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07216443

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • USC / Norris Comprehensive Cancer Center, Los Angeles
Laj 19 ak plis · Tout sèks · Mizajou Apr 2, 2026 · NCT03207854

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Ap rekriteFaz 2
  • Ronald Regan UCLA Medical Center, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT06619561

Etid Sistèm Imunitè ak Twoub nan lòt vil

Lòt etid nan Los Angeles

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.